Cancer BiologybioRxivPreprint
Bidirectional coupling among EMT, AXL-RB1 signaling and lineage switch drives resistance to osimertinib and worse clinical outcomes in NSCLC
Shreya Vashistha, Ritesh Kumar Meena, Prakash Kulkarni…·Mohit Kumar Jolly
DOI 10.64898/2026.04.21.719547